Table 5: Symptom free survival duration (months) in various co-infected subgroups of HIV-1 positive donors.
|
Category of donors |
Subgroups of various co-infections in HIV-1 +ve donors |
|||
|
HPgV +ve (n = 60) |
TTV +ve (n = 48) |
HPgV -ve/TTV -ve (n = 54) |
||
|
Replacement |
Median (95% CI) |
72 (68-74) |
68 (66-72) |
68 (64-71) |
|
Voluntary |
Median (95% CI) |
110* (101-116) |
80 (76-83) |
82 (79-88) |
|
Total subgroup |
Median (95% CI) |
88 (74-101) |
78 (72-80) |
76 (73-81) |
Statistical Comparisons: *Significantly longer duration of symptom free survival in HIV-1/HPgV +ve subgroup compared to other subgroups (p < 0.001 for both comparisons).
Note: Within the replacement category of HIV-1 infected donors with HPgV co-infections, the subcategory showing loss of HPgV viremia on follow up had significantly shorter duration of symptom free survival (Median, 95% CI as 61, 57-64) compared to the subcategory demonstrating persistence of HPgV viremia (Median, 95% CI as 80, 73-86; p < 0.001) at the same point.